Trials / Conditions / Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8

Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8

10 registered clinical trials studyying Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	A Prospective Study of Physical Function in Adults Who Receive Systemic Therapy for Stage I-III Gastroesophage NCT07517211	Jonsson Comprehensive Cancer Center	—
Not Yet Recruiting	Individually Tailored, Supervised, Remote Exercise Intervention to Improve Physical Function for Stage I-III G NCT07439484	Jonsson Comprehensive Cancer Center	N/A
Enrolling By Invitation	Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Paclitaxel for the Treatment of Patients With Gas NCT07139951	Mayo Clinic	Phase 2
Active Not Recruiting	Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastr NCT05836584	National Cancer Institute (NCI)	Phase 2
Recruiting	Preoperative Hypofractionated Radiotherapy With FOLFOX for Esophageal or Gastroesophageal Junction Adenocarcin NCT06078709	Mayo Clinic	Phase 2
Active Not Recruiting	Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of NCT04929392	City of Hope Medical Center	Phase 2
Active Not Recruiting	Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advance NCT04391049	NRG Oncology	Phase 1
Recruiting	Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer NCT03801876	NRG Oncology	Phase 3
Suspended	Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Und NCT03604991	National Cancer Institute (NCI)	Phase 2 / Phase 3
Active Not Recruiting	Phase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal NCT03784326	M.D. Anderson Cancer Center	Phase 2